imidocarb
Sign in to saveAlso known as N,N'-bis(3-(4,5-dihydro-1H-imidazol-2-yl)phenyl)urea, 1,3-bis(3-(2-imidazolin-2-yl)phenyl)urea
Imidocarb is a urea derivative used in veterinary medicine as an antiprotozoal agent for the treatment of infection with Babesia (babesiosis) and other parasites.
Research
350 papers- Antiprotozoal treatment of canine babesiosis.Veterinary parasitology · 2018
- Residue Depletion of Imidocarb in Bovine Tissues by UPLC-MS/MS.Animals : an open access journal from MDPI · 2022
- Diminazene aceturate and imidocarb dipropionate-based combination therapy for babesiosis - A new paradigm.Ticks and tick-borne diseases · 2023
- Pharmacokinetics of imidocarb dipropionate in white-tailed deer (Odocoileus virginianus) after single intramuscular administration.Journal of veterinary pharmacology and therapeutics · 2020
- Pharmacokinetics and bioequivalence of two imidocarb formulations in cattle after subcutaneous injection.PloS one · 2022
via PubMed
~1 min read
Encyclopedic overview
2 sectionsContents
- Mechanism of action
- References
Imidocarb is a urea derivative used in veterinary medicine as an antiprotozoal agent for the treatment of infection with Babesia (babesiosis) and other parasites.
==Mechanism of action== Imidocarb is anticholinergic; it inhibits acetylcholinesterase.
Excerpted from Wikipedia’s “imidocarb” article, available under the CC BY-SA 4.0 licence.